Infertility Testing Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Male Infertility Testing and Female Infertility Testing), Test Kits [Human Follicular Stimulating Hormone (FSH) Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Test Kits, Luteinizing Hormone (LH) Test Kits, and Others], Sample (Blood, Urine, and Others), End User (Hospitals & Clinics, Fertility Centers, and Homecare), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
According to our new research study on “Infertility Testing Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Test Kits, Sample, and End User, Geography” the market is anticipated to grow from US$ 424.20 million in 2022 to US$ 820.08 million by 2030; it is estimated to register a CAGR of 8.6% during 2022–2030. Market growth is attributed to the increasing cases of infertility in men and women and growing advancements in infertility testing. Growing awareness campaigns will likely provide growth opportunities for the infertility testing market. However, the lack of awareness and limitations associated with infertility testing kits hinder the growth of the hyperbaric oxygen therapy market.
According to a study titled “Fertility and Infertility: Definition and Epidemiology,” published in Elsevier B.V., infertility is known to affect around 8–12% of couples across the world. The proportion is gradually increasing due to several causes such as modern lifestyles, illnesses, and the postponement of parenthood. In the male reproductive system, infertility is most often caused by problems ejecting semen, missing or small amounts of sperm, or abnormal shape (morphology) and movement (motility) of sperm. In females, infertility can be caused by abnormalities associated with the uterus, ovaries, fallopian tubes, and endocrine system.
North America accounted for a major share of the global infertility testing market in 2022. The North American infertility testing market is segmented into the US, Canada, and Mexico. The market growth in this region is driven by the high occurrence of infertility, increasing awareness of infertility testing among men and women, the growing female population affected by PCOS, the rising age of first pregnancy among women, and the easy availability of infertility test kits through e-commerce websites. Also, changing lifestyles with increasing trends of unhealthy diets leading to infertility and gynecological disorders in men and women are responsible for the infertility testing market growth. Furthermore, technological advancements in ovulation monitors are bolstering the market growth in the region. Furthermore, the rising consumption of smoking and tobacco will lead to an increase in infertility cases, propelling the market growth. Growing demand for self-testing and remote monitoring testing among women and innovation of new products are expected to create profitable market opportunities.
Growing Awareness Campaigns Fuels the Infertility Testing Market Growth Opportunities
The pregnancy issues among couples have been traditionally blamed on females for being infertile. However, the modern age of human science and in-depth research and studies have led to a shift in the social stigma with a light on infertility among men. Recently, males are being tested and becoming aware of factors responsible for infertility. Although the scenario is improving in some regions of the world, various parts and geographies are still unaware of the availability of new testing and treatment options as well as the condition.
This provides organizations and companies opportunities to hold and organize awareness campaigns that shed light on this sensitive yet important issue faced by a significant percentage of males across the globe. For instance, in November 2020, Nova IVF Fertility in collaboration with the Times of India, initiated a movement called “Fertile Conversations” that hosted social meet-ups and discussions for infertility issues among males and females with experts in the field. In addition, Cooper Genomics, a Cooper Surgical company, launched the National Infertility Awareness Week: Infertility Uncovered campaign to educate the common people regarding the impact of infertility and well-aware patients regarding products and services available with the company to empower families worldwide. Thus, appropriate awareness campaigns are expected to provide robust showcasing platforms for companies, thereby offering growth opportunities to propel revenues within the dynamic ecosystem.
Type -Based Insights
Based on type, the infertility testing market analysis is carried out by considering the following segments: male and female. The female infertility testing segment held a larger market share in 2022. The male infertility testing segment is anticipated to register a higher CAGR of 9.2% during the forecast period.
Declining female fertility rates, increasing prevalence of gynecological issues in women, busier lifestyles of working women leading to more stress, and low egg counts are among the main factors responsible for the high infertility testing market share. Additionally, the availability of many female infertility tests contributes to the market growth for the female infertility testing segment.
Test Kits -Based Insights
By test kits, the infertility testing market is segmented into human follicular stimulating hormone (FSH) test kits, human chorionic gonadotropin (HCG) hormone test kits, luteinizing hormone (LH) test kits, and others. In terms of revenue, the human follicular stimulating hormone (FSH) test kits segment dominated the infertility testing market share in 2022. The highest CAGR of 9.2% is anticipated to be registered during the forecast period.
The follicular stimulating hormone (FSH) test kit helps measure the concentration of FSH hormone in the blood. The test is often used to assess FSH levels in men and women for various reasons such as fertility problems, menopause, or problems with sexual development. In addition, advanced biosimilar FSH products, regulatory approvals, market access, technological advances in FSH kit production, and a growing need for effective contraceptive options are predicted to accelerate global market growth.
End User -Based Insights
The infertility testing market, by end user, is categorized into hospitals & clinics, fertility centers, and homecare. The homecare segment held the largest market share in 2022 and is anticipated to register the highest CAGR of 9.0% during the forecast period.
Leading players are implementing strategies such as expansion, partnership, launch of new products, and acquiring a new customer base to tap prevailing business opportunities.
According to a study titled “Fertility and Infertility: Definition and Epidemiology,” published in Elsevier B.V., infertility is known to affect around 8–12% of couples across the world. The proportion is gradually increasing due to several causes such as modern lifestyles, illnesses, and the postponement of parenthood. In the male reproductive system, infertility is most often caused by problems ejecting semen, missing or small amounts of sperm, or abnormal shape (morphology) and movement (motility) of sperm. In females, infertility can be caused by abnormalities associated with the uterus, ovaries, fallopian tubes, and endocrine system.
North America accounted for a major share of the global infertility testing market in 2022. The North American infertility testing market is segmented into the US, Canada, and Mexico. The market growth in this region is driven by the high occurrence of infertility, increasing awareness of infertility testing among men and women, the growing female population affected by PCOS, the rising age of first pregnancy among women, and the easy availability of infertility test kits through e-commerce websites. Also, changing lifestyles with increasing trends of unhealthy diets leading to infertility and gynecological disorders in men and women are responsible for the infertility testing market growth. Furthermore, technological advancements in ovulation monitors are bolstering the market growth in the region. Furthermore, the rising consumption of smoking and tobacco will lead to an increase in infertility cases, propelling the market growth. Growing demand for self-testing and remote monitoring testing among women and innovation of new products are expected to create profitable market opportunities.
Growing Awareness Campaigns Fuels the Infertility Testing Market Growth Opportunities
The pregnancy issues among couples have been traditionally blamed on females for being infertile. However, the modern age of human science and in-depth research and studies have led to a shift in the social stigma with a light on infertility among men. Recently, males are being tested and becoming aware of factors responsible for infertility. Although the scenario is improving in some regions of the world, various parts and geographies are still unaware of the availability of new testing and treatment options as well as the condition.
This provides organizations and companies opportunities to hold and organize awareness campaigns that shed light on this sensitive yet important issue faced by a significant percentage of males across the globe. For instance, in November 2020, Nova IVF Fertility in collaboration with the Times of India, initiated a movement called “Fertile Conversations” that hosted social meet-ups and discussions for infertility issues among males and females with experts in the field. In addition, Cooper Genomics, a Cooper Surgical company, launched the National Infertility Awareness Week: Infertility Uncovered campaign to educate the common people regarding the impact of infertility and well-aware patients regarding products and services available with the company to empower families worldwide. Thus, appropriate awareness campaigns are expected to provide robust showcasing platforms for companies, thereby offering growth opportunities to propel revenues within the dynamic ecosystem.
Type -Based Insights
Based on type, the infertility testing market analysis is carried out by considering the following segments: male and female. The female infertility testing segment held a larger market share in 2022. The male infertility testing segment is anticipated to register a higher CAGR of 9.2% during the forecast period.
Declining female fertility rates, increasing prevalence of gynecological issues in women, busier lifestyles of working women leading to more stress, and low egg counts are among the main factors responsible for the high infertility testing market share. Additionally, the availability of many female infertility tests contributes to the market growth for the female infertility testing segment.
Test Kits -Based Insights
By test kits, the infertility testing market is segmented into human follicular stimulating hormone (FSH) test kits, human chorionic gonadotropin (HCG) hormone test kits, luteinizing hormone (LH) test kits, and others. In terms of revenue, the human follicular stimulating hormone (FSH) test kits segment dominated the infertility testing market share in 2022. The highest CAGR of 9.2% is anticipated to be registered during the forecast period.
The follicular stimulating hormone (FSH) test kit helps measure the concentration of FSH hormone in the blood. The test is often used to assess FSH levels in men and women for various reasons such as fertility problems, menopause, or problems with sexual development. In addition, advanced biosimilar FSH products, regulatory approvals, market access, technological advances in FSH kit production, and a growing need for effective contraceptive options are predicted to accelerate global market growth.
End User -Based Insights
The infertility testing market, by end user, is categorized into hospitals & clinics, fertility centers, and homecare. The homecare segment held the largest market share in 2022 and is anticipated to register the highest CAGR of 9.0% during the forecast period.
Leading players are implementing strategies such as expansion, partnership, launch of new products, and acquiring a new customer base to tap prevailing business opportunities.
- In August 2023, Trajan Scientific and Medical supplied CE-IVD registered Mitra devices to Fertilly. This German start-up launched Europe's first at-home fertility testing kits using dried blood micro samples with VAMS technology.
- In February 2021, Fertility Focus partnered with ExSeed Health (which deals in at-home sperm testing) to provide solutions for those planning pregnancy.
- In June 2020, Modern Fertility launched ovulation and pregnancy test kits and a mobile application to centralize fertility-related data.
- In March 2020, Proov received FDA approval for its home ovulation test kit.
1. INTRODUCTION
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. RESEARCH METHODOLOGY
4. INFERTILITY TESTING MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. INFERTILITY TESTING MARKET - KEY MARKET DYNAMICS
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. INFERTILITY TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1 Infertility Testing - Global Market Overview
6.2 Infertility Testing - Global Market and Forecast to 2031
7. INFERTILITY TESTING MARKET – REVENUE ANALYSIS (USD MILLION) – BY TYPE, 2021-2031
7.1 Overview
7.2 Female Infertility Testing
7.3 Male Infertility Testing
8. INFERTILITY TESTING MARKET – REVENUE ANALYSIS (USD MILLION) – BY TEST KITS, 2021-2031
8.1 Overview
8.2 Human Follicular Stimulating Hormone (FSH) Urine Test Kits
8.3 Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits
8.4 Luteinizing Hormone (LH) Test Kits
8.5 Others
9. INFERTILITY TESTING MARKET – REVENUE ANALYSIS (USD MILLION) – BY SAMPLE, 2021-2031
9.1 Overview
9.2 Blood
9.3 Urine
9.4 Others
10. INFERTILITY TESTING MARKET – REVENUE ANALYSIS (USD MILLION) – BY END USER, 2021-2031
10.1 Overview
10.2 Hospitals & Clinics
10.3 Fertility Centers
10.4 Homecare
11. INFERTILITY TESTING MARKET - REVENUE ANALYSIS (USD MILLION), 2021-2031 – GEOGRAPHICAL ANALYSIS
11.1 North America
11.1.1 North America Infertility Testing Market Overview
11.1.2 North America Infertility Testing Market Revenue and Forecasts to 2031
11.1.3 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Type
11.1.4 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Test Kits
11.1.5 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Sample
11.1.6 North America Infertility Testing Market Revenue and Forecasts and Analysis - By End User
11.1.7 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Countries
11.1.7.1 United States Infertility Testing Market
11.1.7.1.1 United States Infertility Testing Market, by Type
11.1.7.1.2 United States Infertility Testing Market, by Test Kits
11.1.7.1.3 United States Infertility Testing Market, by Sample
11.1.7.1.4 United States Infertility Testing Market, by End User
11.1.7.2 Canada Infertility Testing Market
11.1.7.2.1 Canada Infertility Testing Market, by Type
11.1.7.2.2 Canada Infertility Testing Market, by Test Kits
11.1.7.2.3 Canada Infertility Testing Market, by Sample
11.1.7.2.4 Canada Infertility Testing Market, by End User
11.1.7.3 Mexico Infertility Testing Market
11.1.7.3.1 Mexico Infertility Testing Market, by Type
11.1.7.3.2 Mexico Infertility Testing Market, by Test Kits
11.1.7.3.3 Mexico Infertility Testing Market, by Sample
11.1.7.3.4 Mexico Infertility Testing Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries
11.2 Europe
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Rest of Europe
11.3 Asia-Pacific
11.3.1 Australia
11.3.2 China
11.3.3 India
11.3.4 Japan
11.3.5 South Korea
11.3.6 Rest of Asia-Pacific
11.4 Middle East & Africa
11.4.1 South Africa
11.4.2 Saudi Arabia
11.4.3 U.A.E
11.4.4 Rest of Middle East & Africa
11.5 South & Central America
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Rest of South & Central America
12. INDUSTRY LANDSCAPE
12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments
13. COMPETITIVE LANDSCAPE
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration
14. INFERTILITY TESTING MARKET - KEY COMPANY PROFILES
14.1 Merck KGaA
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
Note - Similar information would be provided for below list of companies
14.2 Procter & Gamble
14.3 bioMйrieux SA
14.4 Alere Inc.
14.5 Babystart Ltd.
14.6 bioZhena Corporation
14.7 Quidel Corporation
14.8 SCSA Diagnostics, Inc.
14.9 CENTOGENE N.V.
14.10 Boditech Med Inc.
15. APPENDIX
15.1 Glossary
15.2 About The Insight Partners
15.3 Market Intelligence Cloud
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. RESEARCH METHODOLOGY
4. INFERTILITY TESTING MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. INFERTILITY TESTING MARKET - KEY MARKET DYNAMICS
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. INFERTILITY TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1 Infertility Testing - Global Market Overview
6.2 Infertility Testing - Global Market and Forecast to 2031
7. INFERTILITY TESTING MARKET – REVENUE ANALYSIS (USD MILLION) – BY TYPE, 2021-2031
7.1 Overview
7.2 Female Infertility Testing
7.3 Male Infertility Testing
8. INFERTILITY TESTING MARKET – REVENUE ANALYSIS (USD MILLION) – BY TEST KITS, 2021-2031
8.1 Overview
8.2 Human Follicular Stimulating Hormone (FSH) Urine Test Kits
8.3 Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits
8.4 Luteinizing Hormone (LH) Test Kits
8.5 Others
9. INFERTILITY TESTING MARKET – REVENUE ANALYSIS (USD MILLION) – BY SAMPLE, 2021-2031
9.1 Overview
9.2 Blood
9.3 Urine
9.4 Others
10. INFERTILITY TESTING MARKET – REVENUE ANALYSIS (USD MILLION) – BY END USER, 2021-2031
10.1 Overview
10.2 Hospitals & Clinics
10.3 Fertility Centers
10.4 Homecare
11. INFERTILITY TESTING MARKET - REVENUE ANALYSIS (USD MILLION), 2021-2031 – GEOGRAPHICAL ANALYSIS
11.1 North America
11.1.1 North America Infertility Testing Market Overview
11.1.2 North America Infertility Testing Market Revenue and Forecasts to 2031
11.1.3 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Type
11.1.4 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Test Kits
11.1.5 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Sample
11.1.6 North America Infertility Testing Market Revenue and Forecasts and Analysis - By End User
11.1.7 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Countries
11.1.7.1 United States Infertility Testing Market
11.1.7.1.1 United States Infertility Testing Market, by Type
11.1.7.1.2 United States Infertility Testing Market, by Test Kits
11.1.7.1.3 United States Infertility Testing Market, by Sample
11.1.7.1.4 United States Infertility Testing Market, by End User
11.1.7.2 Canada Infertility Testing Market
11.1.7.2.1 Canada Infertility Testing Market, by Type
11.1.7.2.2 Canada Infertility Testing Market, by Test Kits
11.1.7.2.3 Canada Infertility Testing Market, by Sample
11.1.7.2.4 Canada Infertility Testing Market, by End User
11.1.7.3 Mexico Infertility Testing Market
11.1.7.3.1 Mexico Infertility Testing Market, by Type
11.1.7.3.2 Mexico Infertility Testing Market, by Test Kits
11.1.7.3.3 Mexico Infertility Testing Market, by Sample
11.1.7.3.4 Mexico Infertility Testing Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries
11.2 Europe
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Rest of Europe
11.3 Asia-Pacific
11.3.1 Australia
11.3.2 China
11.3.3 India
11.3.4 Japan
11.3.5 South Korea
11.3.6 Rest of Asia-Pacific
11.4 Middle East & Africa
11.4.1 South Africa
11.4.2 Saudi Arabia
11.4.3 U.A.E
11.4.4 Rest of Middle East & Africa
11.5 South & Central America
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Rest of South & Central America
12. INDUSTRY LANDSCAPE
12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments
13. COMPETITIVE LANDSCAPE
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration
14. INFERTILITY TESTING MARKET - KEY COMPANY PROFILES
14.1 Merck KGaA
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
Note - Similar information would be provided for below list of companies
14.2 Procter & Gamble
14.3 bioMйrieux SA
14.4 Alere Inc.
14.5 Babystart Ltd.
14.6 bioZhena Corporation
14.7 Quidel Corporation
14.8 SCSA Diagnostics, Inc.
14.9 CENTOGENE N.V.
14.10 Boditech Med Inc.
15. APPENDIX
15.1 Glossary
15.2 About The Insight Partners
15.3 Market Intelligence Cloud
